MedTrace Logo

Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers

NCT01997879 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2023-08-22

No results posted yet for this study

Summary

The purpose of this study is to assess systemic safety and absorption of AR-13324 in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

AR-13324 Ophthalmic Solution, 0.02%

Eyedrop

Sponsors & Collaborators

  • Aerie Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01997879 on ClinicalTrials.gov